New Zealand markets open in 3 hours 4 minutes

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.8100-0.5100 (-11.81%)
At close: 04:00PM EST
3.8500 +0.04 (+1.05%)
After hours: 07:29PM EST
Full screen
Trade prices are not sourced from all markets
Previous close4.3200
Open3.8000
Bid3.7100 x 800
Ask3.8600 x 1000
Day's range3.6800 - 4.1100
52-week range3.6800 - 13.3600
Volume299,912
Avg. volume223,825
Market cap11.802M
Beta (5Y monthly)0.72
PE ratio (TTM)N/A
EPS (TTM)-2.5700
Earnings date14 Feb 2022 - 18 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China

    WOODSTOCK, Ga., January 20, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has added Salus Medical as an additional distribution partner in the United States for dental care and expanded its oral and dental care li

  • Business Wire

    Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022

    WOODSTOCK, Ga., January 05, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions, today announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference. The conference is being held on January 10-13, 2022 virtually.

  • Business Wire

    Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results

    WOODSTOCK, Ga., November 15, 2021--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its second fiscal quarter and six months ended September 30, 2021.